יתרות המזומנים של החברה savarapharma.com (SVRA)

The cash-on-hand metric helps assess the financial stability of Savara Inc. (SVRA), which is protected by patents in the orphan lung disease niche. Environmental policies necessitate expenditures for chemical disposal, while the completion of clinical trials for a new inhaler requires a concentration of capital. The value of 0.12 serves as a current liquidity indicator, reflecting the trend of reserve accumulation amid tight monetary policy.
פילוחים אנליטיים ודוחות נתונים של חברת Savara Inc (SVRA)

This indicator tracks the volume of liquid assets on accounts, determining the organization's ability to service current liabilities without external borrowing. By analyzing the cash structure, an investor assesses the cash runway of Savara Inc. (SVRA), which is critical for ensuring the commercial launch of molgramostim and covering operating expenses until the drug is fully integrated into insurance programs.